Official SEC submissions
CNS Pharmaceuticals SEC Filings
Direct answer
CNS Pharmaceuticals's latest SEC filing is DEFA14A.
Get free CNS Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Recent SEC filings
DEF 14A
Proxy statement
Filed:
Report date:
DEFINITIVE NOTICE AND PROXY STATEMENT
4
Insider transaction
Filed:
Report date:
4
Insider transaction
Filed:
Report date:
4
Insider transaction
Filed:
Report date:
10-K/A
Periodic report
Filed:
Report date:
AMENDMENT #1 TO FORM 10-K
4
Insider transaction
Filed:
Report date:
4
Insider transaction
Filed:
Report date:
4
Insider transaction
Filed:
Report date:
4
Insider transaction
Filed:
Report date:
4
Insider transaction
Filed:
Report date:
4
Insider transaction
Filed:
Report date:
4
Insider transaction
Filed:
Report date:
4
Insider transaction
Filed:
Report date:
4
Insider transaction
Filed:
Report date:
4
Insider transaction
Filed:
Report date:
10-K/A
Periodic report
Filed:
Report date:
AMENDMENT NO. 1 TO FORM 10-K
Verified data
- Recent filing categories
- 5
- Recent filings
- 40
- SEC CIK
- 0001729427
- Latest filing date
- August 25, 2026